Group One Trading’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,131
| Closed | -$22.2K | – | 5658 |
|
|
2017
Q4 | $19K | Sell |
1,131
-10,272
| -90% | -$188K | ﹤0.01% | 4178 |
|
|
2017
Q3 | $231K | Buy |
+11,403
| New | +$218K | ﹤0.01% | 2667 |
|
|
2017
Q2 | – | Sell |
-57,013
| Closed | -$842K | – | 5376 |
|
|
2017
Q1 | $721K | Buy |
57,013
+55,024
| +2,766% | +$665K | 0.01% | 1583 |
|
|
2016
Q4 | $26K | Buy |
+1,989
| New | +$34K | ﹤0.01% | 3600 |
|
|
2016
Q3 | – | Sell |
-7,383
| Closed | -$198K | – | 5177 |
|
|
2016
Q2 | $213K | Buy |
7,383
+1,471
| +25% | +$47.9K | ﹤0.01% | 2356 |
|
|
2016
Q1 | $189K | Buy |
5,912
+5,549
| +1,529% | +$195K | ﹤0.01% | 2357 |
|
|
2015
Q4 | $16K | Buy |
+363
| New | +$14.5K | ﹤0.01% | 4026 |
|
|
2015
Q3 | – | Sell |
-11,306
| Closed | -$509K | – | 5472 |
|
|
2015
Q2 | $519K | Sell |
11,306
-11,478
| -50% | -$545K | 0.01% | 1756 |
|
|
2015
Q1 | $1.07M | Buy |
+22,784
| New | +$907K | 0.02% | 1030 |
|
|
2014
Q3 | – | Sell |
-4,216
| Closed | -$108K | – | 5655 |
|
|
2014
Q2 | $126K | Sell |
4,216
-17,614
| -81% | -$475K | ﹤0.01% | 2778 |
|
|
2014
Q1 | $577K | Buy |
21,830
+21,711
| +18,245% | +$543K | 0.01% | 1537 |
|
|
2013
Q4 | $3K | Sell |
119
-10,387
| -99% | -$232K | ﹤0.01% | 5006 |
|
|
2013
Q3 | $215K | Sell |
10,506
-3,244
| -24% | -$67K | ﹤0.01% | 2321 |
|
|
2013
Q2 | $274K | Buy |
+13,750
| New | +$244K | 0.01% | 1872 |
|
Group One Trading's IPXL Position: Q1 2018 in Review
Group One Trading sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 1,131 shares — an estimated $22.2K sold.
Group One Trading first reported a position in IPXL in Q2 2013 and held it in 14 quarters. The position peaked at $1.07M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.
- Group One Trading reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
- Group One Trading sold 1,131 Impax Laboratories, Inc. shares in Q1 2018, an estimated $22.2K.
- Group One Trading first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 14 quarters.
- Group One Trading's Impax Laboratories, Inc. position peaked at $1.07M in Q1 2015.
- 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.
Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.